Brugada syndrome and job fitness: report of three cases.


Journal

Industrial health
ISSN: 1880-8026
Titre abrégé: Ind Health
Pays: Japan
ID NLM: 2985065R

Informations de publication

Date de publication:
06 Dec 2023
Historique:
medline: 11 12 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Brugada syndrome (BrS) is an inherited arrhythmogenic disorder predisposing patients to a high risk of sudden cardiac death. Specific guidelines on the health surveillance of BrS workers are lacking. We report here three cases requiring assessment of specific job capacity, investigated with an interdisciplinary protocol including 24-h Holter electrocardiography with modified precordial leads, pharmacological test with ajmaline, molecular genetic analysis, electrophysiological study with ventricular stimulation, risk stratification, and occupational medicine evaluation: (1) a female 42-yr-old company manager with positive ajmaline test and CACNA1C gene mutation (judged fit for the job with limitations regarding work-related stress); (2) a male 44-yr-old welder with positive ajmaline test, SCN5A gene mutation, and associated OSAS (obstructive sleep apnea syndrome), who was advised to refrain from night shifts and driving company vehicles; (3) a male 45-yr-old electrical technician with inducible ventricular tachyarrhythmia, who was implanted with a biventricular cardioverter defibrillator, and therefore recommended to avoid exposure to electromagnetic fields and working at heights. We conclude that the collaboration between the cardiologist and the occupational physician allows defining the functional capabilities and the arrhythmogenic risk of BrS workers, to optimize job fitness assessment.

Identifiants

pubmed: 36724992
doi: 10.2486/indhealth.2022-0205
doi:

Substances chimiques

Ajmaline 1PON08459R

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-461

Auteurs

Stefano M Candura (SM)

Occupational Medicine Unit, Department of Public Health, Experimental and Forensic Sciences, University of Pavia, Italy.
Istituti Clinici Scientifici Maugeri IRCCS, Occupational Medicine Unit of Pavia Institute, Italy.

Daniela Vanoli (D)

Occupational Medicine Unit, Department of Public Health, Experimental and Forensic Sciences, University of Pavia, Italy.

Andrea Mazzanti (A)

Istituti Clinici Scientifici Maugeri IRCCS, Molecular Cardiology of Pavia Institute, Italy.
Department of Molecular Medicine, University of Pavia, Italy.
Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain.

Luca D'Amato (L)

Occupational Medicine Unit, Department of Public Health, Experimental and Forensic Sciences, University of Pavia, Italy.

Silvia G Priori (SG)

Istituti Clinici Scientifici Maugeri IRCCS, Molecular Cardiology of Pavia Institute, Italy.
Department of Molecular Medicine, University of Pavia, Italy.

Fabrizio Scafa (F)

Istituti Clinici Scientifici Maugeri IRCCS, Occupational Medicine Unit of Pavia Institute, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH